致幻剂用于心理健康的科学 | Robin Carhart-Harris 博士

这 section of the episode develops the topic 通过 the following source points: ANDREW HUBERMAN: Welcome to the Huberman Lab 播客, where 我们 discuss science 和 science-based tools 对于 everyday life. [MUSIC PLAYING] I'm Andrew Huberman, 和 I'm a professor of 神经生物学 和 ophthalmology at Stanford School of Medicine. Today, my guest is Dr. Robin Carhart-Harris. Dr. Carhart-Harris is a distinguished professor of neurology 和 psychiatry at the University of California, San Francisco. He is 一 of the leading researchers in the field of psychedelics 和 how they change neural circuitry in the 大脑. His laboratory is responsible 对于 understanding, 对于 instance, how psilocybin, also sometimes referred to as magic mushrooms change neural circuitry in the 大脑, such 那 new ideas 和 new forms of learning occur. His laboratory is also responsible 对于 carrying out various clinical trials, some of which have demonstrated 那 appropriate dosages of psilocybin 可以 alleviate major depression in 更多 than 67% of 人们 那 take the drug. Now, 这 is not to say 那 everybody 应该 take psilocybin, 和 today's discussion describes both the clinical trials 和 why treatments 与 psychedelics in some cases work 和 in some cases do not work in order to treat major depression. As well as discussions 大约 psilocybin, lysogenic acid diethylamide, sometimes also referred to as LSD, as well as DMT. 和 how 这些 change the 大脑, 和 how 那些 大脑 changes 可以 relate to changes in 心理健康, as it relates to depression 和 other psychiatric challenges, as well as how psychedelics are being applied in order to change neural circuitry 对于 sake of expanding 不同的 aspects of the human 心智, including creativity, intelligence, 和 much 更多.